CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials

Fang, Z., Liu, M., Tao, J., Li, C., Zou, F., Zhang, W. · 2022 · Journal of Endocrinological Investigation

Abstract

Background Controversy remains regarding whether closed-loop (CL) insulin delivery or insulin sensor-augmented pump (SAP) delivery is more efficient for clinical treatment. Therefore, we aimed to compare the efficacy and safety of CL insulin delivery systems versus insulin SAP delivery for adults with type 1 diabetes (T1D). Methods Embase, Ovid MEDLINE, PubMed, ScienceDirect, Scopus, the Cochrane Library, and other databases were searched for related articles, and we analyzed the average blood glucose (BG), time in range (TIR), and adverse effects (AEs) as primary endpoints to evaluate efficacy and safety. Results Of 1616 articles, 12 randomized-controlled trials (RCTs) were included in the final analysis. Regarding BG control efficacy, CL insulin delivery resulted better outcomes than SAP therapy with regard to the average BG value, which was detected and recorded by continuous glucose monitoring (mean difference [MD][mmol/L]: - 0.25 95% confidence interval [CI] - 0.42 to - 0.08, p = 0.003); TIR 3.9-10 mmol/L (MD [%]: 7.91 95% CI 4.45-11.37, p Conclusions CL insulin delivery appears to be a better treatment method than SAP therapy for adults with T1D because of its increased BG control efficacy and decreased number of hypoglycemic events.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40618-021-01674-6

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL et al (2016) Overnight closed-loop (OCL) at home compared with sensor-augmented pump with low-glucose suspend (SAP-LGS) improves time in target range in adults and reduces hypoglycemia in adolescents. Diabetes 65(Supplement 1):A1–A100

Cited by

See all 40

Metadata

Authors
Fang, Z., Liu, M., Tao, J., Li, C., Zou, F., & Zhang, W.
Affiliations
  • Nanchang University (CN)
  • Second Affiliated Hospital of Nanchang University (CN)
Corresponding author
Zhang, W.
Venue
Journal of Endocrinological Investigation
Published
2021-09-17
Volume
45
Issue
3
Pages
471-481
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
OpenAlex
W3199858196
Cited by
38
References
32
Citations by year
2026: 6 · 2025: 3 · 2024: 9 · 2023: 13 · 2022: 7
FWCI
1.12
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Endocrinological Investigation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • national natural science foundation of china (81560345)
  • natural science foundation of jiangxi province (20181BAB215027)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
artificial pancreas, sensor-augmented pump, type 1 diabetes, continuous glucose monitoring, glycemic control, time in range, hypoglycemia, glycemic variability, insulin pump therapy, adults with type 1 diabetes, hypoglycemia risk reduction, hypoglycemia education
MeSH terms
Adult, Diabetes Mellitus, Type 1, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Treatment Outcome, Patient Safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials. https://app.cochat.ai/papers/10.1007/s40618-021-01674-6
The paper
Fang, Z., Liu, M., Tao, J., Li, C., Zou, F., & Zhang, W. (2022). Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-021-01674-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.